Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-395827

Chief Business Officer acquired 17,493 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robb Gary Charles · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-17 Exercise or conversion : show line 1 in the form +17,493 $8.27 $144,667 31,156 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-17 Exercise or conversion : show line 2 in the form Stock option (right to buy) −17,493 182,507 D
Loading xslF345X06/ownership.xml…